Number of the records: 1
neoplázia endokrinná mnohopočetná, typ 2b
SYS d018814 LBL 00000cx--j22000003--45-- 005 20240119201321.2 100 $a 19940523csloy0103----ba0 152 $b mesh 250 $a neoplázia endokrinná mnohopočetná, typ 2b $x BL $x BS $x CF $x CH $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SC $x SU $x TH $x UL $x UR $x VE $x VI $8 slo 300 1-
$a 1995; MEA III & MEN III see NEOPLASMS, MULTIPLE ENDOCRINE 1983-1994 $8 eng 300 1-
$a Multiple Endocrine Neoplasia (1975-1994) $8 eng 330 1-
$a Similar to MEN2A, it is also caused by mutations of the MEN2 gene, also known as the RET proto-oncogene. Its clinical symptoms include medullary carcinoma (CARCINOMA, MEDULLARY) of THYROID GLAND and PHEOCHROMOCYTOMA of ADRENAL MEDULLA (50%). Unlike MEN2a, MEN2b does not involve PARATHYROID NEOPLASMS. It can be distinguished from MEN2A by its neural abnormalities such as mucosal NEUROMAS on EYELIDS; LIP; and TONGUE, and ganglioneuromatosis of GASTROINTESTINAL TRACT leading to MEGACOLON. It is an autosomal dominant inherited disease. $8 eng 450 $a MEN 2b $5 e $8 eng 450 $a MEN 3 $5 e $8 eng 450 $a Neoplasia, Multiple Endocrine Type 2b $5 e $8 eng 450 $a Neoplasms, Multiple Endocrine Type 2b $5 e $8 eng 450 $a nádory endokrinné mnohopočetné, typ 2b $5 e $8 slo 450 $a MEN2b $5 e $8 slo 450 $a MEN 2b $5 e $8 slo 450 $a MEN 3 $5 e $8 slo 550 $3 sllk_un_auth*d010673 $Y Pheochromocytoma $5 B $a feochromocytóm 550 $3 sllk_un_auth*d018276 $Y Carcinoma, Medullary $5 B $a karcinóm medulárny 686 $a C04.588.322.400.510 686 $a C04.651.600.510 686 $a C04.700.630.510 686 $a C16.320.700.630.510 686 $a C19.344.400.510 750 $a Multiple Endocrine Neoplasia Type 2b $8 eng 801 -0
$a US $b DNLM $c 19940523 801 -2
$a SK $b BA006 $c 20060419 820 $a coordinate IM with specific endocrine/neoplasm pre-coordinates (IM) + specific histological type (IM) if pertinent $8 eng 980 $x M
Number of the records: 1